Biolinq, Inc.
ID: 5331089Biolinq, Inc. is a Needle-Free Blood Glucose Monitoring founded by Joshua Windmiller.
5
Funding Rounds
$138.3m
Money raised
Recent Funding Rounds
Overview
Biolinq, Inc. is a Needle-Free Blood Glucose Monitoring founded by Joshua Windmiller.
- Website:
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja*** Ta***** |
|
- | |
| Jo**** Wi******** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Na*** A Ho** | - | - | linkedin twitter |
Funding series
Funding Series Analysis
The company Biolinq, Inc. has raised a total of $10m in funding over 5 rounds.
Key Insights:
- Biolinq, Inc. Series A round, November 2017: $10m
- Biolinq Inc funding round, September 2021: $109.51m
- Biolinq Inc funding round, April 2020: $8m
- Biolinq Inc funding round, March 2021: $6m
- Biolinq funding round, March 2019: $4.75m
Industries
Biolinq, Inc. is active in the following industries: